The Immunohistochemical Expression of MCM-3, -5, and -7 Proteins in the Uterine Fibroids
Open Access
- 25 July 2021
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 43 (2), 802-817
- https://doi.org/10.3390/cimb43020058
Abstract
Uterine fibroids are the most common mesenchymal uterine neoplasms; their prevalence is estimated in 40%–60% of women under 35 and in 70%–80% of women over 50 years of age. The current research aims to focus on the etiopathogenesis of uterine fibroids, the factors that affect their growth, and markers with diagnostic and prognostic properties. The MCM (minichromosome maintenance) protein family consists of peptides whose primary function is participation in the molecular mechanism of creating replication forks while regulating DNA synthesis. The aim of this work was to determine the proliferative potential of uterine fibroid cells based on the expression of the Ki-67 antigen and the MCMs—i.e., MCM-3, MCM-5, and MCM-7. In addition, the expression of estrogen (ER) and progesterone (PgR) receptors was evaluated and correlated with the expression of the abovementioned observations. Ultimately, received results were analyzed in terms of clinical and pathological data. Materials and methods: In forty-four cases of uterine fibroids, immunohistochemical reactions were performed. A tissue microarray (TMA) technique was utilized and analyzed cases were assessed in triplicate. Immunohistochemistry was performed using antibodies against Ki-67 antigen, ER, PgR, MCM-3, MCM-5, and MCM-8 on an automated staining platform. Reactions were digitalized by a histologic scanner and quantified utilizing dedicated software for nuclear analysis. Assessment was based on quantification expression of the three histiospots, each representing one case in TMA. Results: In the study group (uterine fibroids), statistically significant stronger expression of all the investigated MCMs was observed, as compared to the control group. In addition, moderate and strong positive correlations were found between all tested proliferative markers. The expression of the MCM-7 protein also correlated positively with ER and PgR. With regard to clinical and pathological data, there was a negative correlation between the expression of MCMs and the number of both pregnancies and births. Significant reductions in MCM-5 and MCM-7 expression were observed in the group of women receiving oral hormonal contraceptives, while smoking women showed an increase in MCM-7, ER, and PgR. Conclusions: Uterine fibroid cells have greater proliferative potential, as evaluated by expression of the Ki-67 antigen and MCMs, than unaltered myometrial cells of the uterine corpus. The expression of MCM-7 was found to have strong or moderate correlations in all assessed relations. In the context of the clinical data, as well evident proliferative potential of MCMs, further studies are strongly recommended.Keywords
This publication has 67 references indexed in Scilit:
- High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanomaDiagnostic Pathology, 2012
- miR-93/106b and Their Host Gene, MCM7, Are Differentially Expressed in Leiomyomas and Functionally Target F3 and IL-8Molecular Endocrinology, 2012
- Diagnostic value of progesterone receptor and p53 expression in uterine smooth muscle tumorsDiagnostic Pathology, 2012
- Reproductive characteristics and risk of uterine leiomyomataFertility and Sterility, 2010
- Association of Intrauterine and Early-Life Exposures with Diagnosis of Uterine Leiomyomata by 35 Years of Age in the Sister StudyEnvironmental Health Perspectives, 2010
- Risk factors for surgically removed fibroids in a large cohort of teachersFertility and Sterility, 2009
- The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sistersAmerican Journal of Obstetrics and Gynecology, 2008
- MCM immunocytochemistry as a first line cervical screening test in developing countries: a prospective cohort study in a regional cancer centre in IndiaBritish Journal of Cancer, 2007
- Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse modelProceedings of the National Academy of Sciences of the United States of America, 2006
- Progesterone blocks estrogen-induced DNA synthesis through the inhibition of replication licensingProceedings of the National Academy of Sciences of the United States of America, 2006